首頁
Prime Medicine, Inc.

7月 2026Prime Medicine, Inc.的市場佔有率分析

-2803

健康 > 生物技術和製藥

域名primemedicine.com

成立年份2019

僱員51 - 200

年度營收$2M - $5M

Prime Medicine, Inc.

Prime Medicine, Inc.（包含公司地區）

primemedicine.com

查看更多網站流量與參與度資訊

Prime Medicine, Inc.截至 7月 2026 的總收入為 2M - 5M

Prime Medicine, Inc. 熱門網域產生的總收入

Prime Medicine, Inc. 熱門網域 3 年內的總收入

Prime Medicine, Inc. 熱門網域的總收入

primemedicine.com2M - 5M

透過銷售情報查看更多內容

7月 2026Prime Medicine, Inc.的股票價格

Prime Medicine, Inc. 股票交易代碼 #PRME。以下是截至 7月 2026Prime Medicine, Inc. 過去 12 個月的股票績效

Prime Medicine, Inc.的熱門網域總造訪量

了解Prime Medicine, Inc.市場觸達率與潛在市場影響力。

過去 3 個月的訪問總量

子公司細目

primemedicine.com15K

透過銷售情報查看更多內容

Prime Medicine, Inc.的熱門網域平均造訪時長

分析Prime Medicine, Inc.參與度指標。

過去 3 個月平均造訪時長

子公司細目

primemedicine.com00:00:25

透過銷售情報查看更多內容

Prime Medicine, Inc.的熱門網域平均頁面瀏覽量

了解Prime Medicine, Inc.如何保持使用者的參與度、培養其興趣，並鼓勵他們採取下一步。

過去 3 個月平均頁面瀏覽量

子公司細目

primemedicine.com1.86

透過銷售情報查看更多內容

Prime Medicine, Inc.按網域劃分的熱門競爭對手

7月 2026的熱門類似網站，依相似度排名

sana.com公司名Sana Biotechnology, Inc.僱員201 - 500總部美國, 華盛頓, Seattle年度營收$100M - $200M訪問總量23.4K電腦電子與科技 > 圖形多媒體和網頁設計

使用的熱門技術Prime Medicine, Inc.

这些是Prime Medicine, Inc.顶级域名使用的行业网站技术

內容管理系統 (3)

WordPress

付費廣告 (2)

DoubleClick

轉換與分析 (2)

Google Analytics

電子郵件服務 (2)

GoDaddy Email

更多技術

7

檢視所有

新聞與訊號來自Prime Medicine, Inc.

透過 Similarweb 銷售訊號提醒，每當目標受眾出現新的機會或威脅時，你就會收到每日更新的已識別購買訊號。

新聞Prime Medicine, Inc. is developing PM647 for alpha-1 antitrypsin deficiency on Jul 8th '26.Beam Therapeutics tumbled nearly 9% following the July 8 arbitration ruling that awarded rival Prime Medicine the right to develop PM647 for alpha-1 antitrypsin deficiency - injecting competitive uncertainty into the BEAM-302 AATD program just as the stock had recently touched a 52-week high near $38.

新聞Prime Medicine, Inc. attended event Goldman Sachs 47th Annual Global Healthcare Conference on Jun 10th '26.CAMBRIDGE, Mass., June 03, 2026 (GLOBE NEWSWIRE) - Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced that Allan Reine, M.D., Chief Executive Officer of Prime Medicine, will participate in a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference on Wednesday, June 10, 2026, at 10:40 a.m. ET in Miami Beach, FL.

新聞Prime Medicine, Inc. attended event 2026 ASGCT Annual Meeting on May 11th '26.Prime Medicine will be speaking about their collaboration with Benchling at the 2026 ASGCT Annual Meeting, Monday May 11th, as part of the Automation in CGT Manufacturing workshop.